Fractyl Health to Participate in Upcoming September Investor Conferences
Fractyl Health’s CEO will present and meet investors at two September 2026 healthcare investment conferences, with webcasts available for 90 days.
Rhea-AI Summary
Fractyl Health (GUTS) will participate in two investor conferences in September 2026 featuring CEO Harith Rajagopalan. The company will present an on-demand session and hold one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference, with the presentation available starting September 11, 2026 at 7:00 AM ET and meetings on September 15, 2026. Fractyl will also host a fireside chat and one-on-one meetings at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026 at 5:35 PM ET. Live and on-demand webcasts for both events will be available via the Events section of the company’s investor relations website and will remain accessible for 90 days.
Positive
- None.
Negative
- None.
Details
Market Reaction – GUTS
Following this news, GUTS has gained 1.72%, reflecting a mild positive market reaction. Our momentum scanner has triggered 2 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $0.70.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Terms
t2d medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of the Company, will be participating in the following upcoming investor conferences:
H.C. Wainwright 28th Annual Global Investment Conference
Format: On-demand presentation and one-on-one meetings
Presentation available beginning Friday, September 11, 2026 at 7:00 AM ET
One-on-one meetings: Tuesday, September 15, 2026
Morgan Stanley 24th Annual Global Healthcare Conference
Format: Fireside chat and one-on-one meetings
Date: Monday, September 14, 2026
Time: 5:35 PM ET
Live and on-demand webcasts of each event can be accessed in the “Events” section of Fractyl Health’s website at http://ir.fractyl.com. Each webcast will be archived and available for replay for 90 days following the live event.
About Fractyl Health
Fractyl is a clinical-stage metabolic therapeutics company advancing two differentiated candidates designed to target the root causes of obesity and T2D: Revita, a procedural therapy in pivotal development for post-GLP-1 weight maintenance, and Rejuva, an AAV-based gene therapy platform with its lead candidate RJVA-001 entering first-in-human clinical studies. Fractyl’s goal is to advance metabolic disease treatment from chronic management toward prevention and reversal of disease. Fractyl is headquartered in Burlington, Massachusetts.
Contact
Brian Luque, Head of Investor Relations and Corporate Development
IR@fractyl.com, 951.206.1200
FAQ
How can investors access Fractyl Health’s presentations at these conferences?
Live and on-demand webcasts of each event can be accessed in the “Events” section of Fractyl Health’s investor relations website at http://ir.fractyl.com. Each webcast will be archived and available for replay for 90 days following the live event.
What is the format and timing of Fractyl Health’s participation at the H.C. Wainwright conference?
At the H.C. Wainwright 28th Annual Global Investment Conference, Fractyl Health will provide an on-demand presentation available beginning Friday, September 11, 2026 at 7:00 AM ET and will conduct one-on-one meetings on Tuesday, September 15, 2026.
What is the format and timing of Fractyl Health’s session at the Morgan Stanley conference?
At the Morgan Stanley 24th Annual Global Healthcare Conference, Fractyl Health will participate in a fireside chat and one-on-one meetings on Monday, September 14, 2026, with the session scheduled for 5:35 PM ET. A webcast will be available live and on-demand.
Who will represent Fractyl Health at these investor conferences?
The company will be represented by Harith Rajagopalan, M.D., Ph.D., who is the Co-Founder and Chief Executive Officer of Fractyl Health.